Home / Stocks / ASRRF

ASR Nederland N.V. (ASRRF, Multi-line Insurance) Stock Valuation & Fair Value Significantly overvalued

ASR Nederland N.V. (ASRRF, Multi-line Insurance) trades at a blended P/E of 12.3, about 64% above its historical normal valuation, with a forward growth estimate of 5.3% and a PEG of 2.31. Analysts' one-year estimates have been hit 44% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

Blended P/E
12.3
Normal P/E
7.5
PEG
2.31
Fwd growth
5.3%
Div yield
4.8%
RSI (14)
100.0
Overbought

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-09-19.

Blended P/E and rating by weekBlended P/E moved from 12.3 to 12.3 between 2026-09-19 and 2026-09-21, against a normal P/E of 7.5, with 0 rating changes over 2 recorded weeks.2026-09-19: P/E 12.3, Significantly overvalued (recalculated)2026-09-21: P/E 12.3, Significantly overvalued8.010.012.0Sep 19Sep 20Sep 21Normal P/E 7.5
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Ratings recorded live since 2026-09-21. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.

WeekBlended P/EPremium to normal P/ERating
2026-09-19P/E 12.3+64%Significantly overvalued
2026-09-21P/E 12.3+64%Significantly overvalued ← now

Frequently asked questions

Is ASR Nederland N.V. stock overvalued?

At a blended P/E of 12.3 versus its historical normal P/E of 7.5, ASR Nederland N.V. trades about 64% above its typical valuation, with a PEG of 2.31 on 5.3% forward growth. tickerseer currently rates it significantly overvalued.

What is ASR Nederland N.V.'s fair value and PEG?

ASR Nederland N.V. trades at a blended P/E of 12.3 against a historical normal P/E of 7.5, a PEG of 2.31, and a forward growth estimate of 5.3%.

Has tickerseer's rating of ASR Nederland N.V. changed?

tickerseer's rating has been significantly overvalued since 2026-09-19.

Industry: Multi-line Insurance. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.